| Dr Adam Nassery, MD | |
|
21000 Ne 28th Ave, Aventura, FL 33180 | |
| (305) 974-5533 | |
| (305) 974-5553 |
| Full Name | Dr Adam Nassery |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 10 Years |
| Location | 21000 Ne 28th Ave, Aventura, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275952863 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | ME140811 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aventura Hospital And Medical Center | Aventura, FL | Hospital |
| Jackson Health System | Miami, FL | Hospital |
| Mount Sinai Medical Center | Miami beach, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christian Gonzalez Md Llc | 9335389659 | 10 |
News Archive
Patients who have a clot in their legs and are considering whether to be treated with traditional blood-thinning medication or undergo a minimally-invasive catheter-based clot removal procedure should feel comfortable that there is no difference in death rates between the two treatments, although there are more bleeding risks with the catheter procedure, according to a study by Temple University School of Medicine researchers.
Indian health experts say the findings of a US study — which suggest that population density is unrelated to COVID-19 infection rates — to be completely contradictory to their experience of dealing with the pandemic in India, a country with 1.3 billion people.
Momenta Pharmaceuticals, Inc. a biotechnology company specializing in the characterization and engineering of complex drugs, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,816,144, entitled "Evaluating Mixtures of Low Molecular Weight Heparins By Chain Profiles or Chain Mapping". The patent includes claims to methods of analyzing and processing enoxaparin by analyzing chain sequence information.
The diagnosis of myelodysplastic syndrome, a blood cancer, often causes confusion. While some patients can be treated with repeated blood transfusions, others require chemotherapy, leaving some uncertainty about whether the syndromes actually are cancer.
Hill-Rom announced today organizational changes consistent with its on-going efforts to improve its cost structure. The changes include the elimination of approximately 160 positions throughout the company.
› Verified 3 days ago
| Entity Name | Christian Gonzalez Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568809325 PECOS PAC ID: 9335389659 Enrollment ID: O20130710000590 |
News Archive
Patients who have a clot in their legs and are considering whether to be treated with traditional blood-thinning medication or undergo a minimally-invasive catheter-based clot removal procedure should feel comfortable that there is no difference in death rates between the two treatments, although there are more bleeding risks with the catheter procedure, according to a study by Temple University School of Medicine researchers.
Indian health experts say the findings of a US study — which suggest that population density is unrelated to COVID-19 infection rates — to be completely contradictory to their experience of dealing with the pandemic in India, a country with 1.3 billion people.
Momenta Pharmaceuticals, Inc. a biotechnology company specializing in the characterization and engineering of complex drugs, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,816,144, entitled "Evaluating Mixtures of Low Molecular Weight Heparins By Chain Profiles or Chain Mapping". The patent includes claims to methods of analyzing and processing enoxaparin by analyzing chain sequence information.
The diagnosis of myelodysplastic syndrome, a blood cancer, often causes confusion. While some patients can be treated with repeated blood transfusions, others require chemotherapy, leaving some uncertainty about whether the syndromes actually are cancer.
Hill-Rom announced today organizational changes consistent with its on-going efforts to improve its cost structure. The changes include the elimination of approximately 160 positions throughout the company.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adam Nassery, MD Po Box 223190, Hollywood, FL 33022-3190 Ph: (305) 974-5533 | Dr Adam Nassery, MD 21000 Ne 28th Ave, Aventura, FL 33180 Ph: (305) 974-5533 |
News Archive
Patients who have a clot in their legs and are considering whether to be treated with traditional blood-thinning medication or undergo a minimally-invasive catheter-based clot removal procedure should feel comfortable that there is no difference in death rates between the two treatments, although there are more bleeding risks with the catheter procedure, according to a study by Temple University School of Medicine researchers.
Indian health experts say the findings of a US study — which suggest that population density is unrelated to COVID-19 infection rates — to be completely contradictory to their experience of dealing with the pandemic in India, a country with 1.3 billion people.
Momenta Pharmaceuticals, Inc. a biotechnology company specializing in the characterization and engineering of complex drugs, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,816,144, entitled "Evaluating Mixtures of Low Molecular Weight Heparins By Chain Profiles or Chain Mapping". The patent includes claims to methods of analyzing and processing enoxaparin by analyzing chain sequence information.
The diagnosis of myelodysplastic syndrome, a blood cancer, often causes confusion. While some patients can be treated with repeated blood transfusions, others require chemotherapy, leaving some uncertainty about whether the syndromes actually are cancer.
Hill-Rom announced today organizational changes consistent with its on-going efforts to improve its cost structure. The changes include the elimination of approximately 160 positions throughout the company.
› Verified 3 days ago
Anthony Louis Paglia, M.D. Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 21110 Biscayne Blvd Ste 205, Aventura, FL 33180 Phone: 954-458-1199 Fax: 954-458-1833 |